Macular edema (ME) is a major complication of several vascular and inflammatory retinal
diseases. Multiple mechanisms are implicated in its development and lead to visual …

Introduction Diabetic retinopathy (DR) is one of the main pathological features of the
diabetes mellitus spectrum. It is estimated that in 2020 about 4 million people worldwide …

Age-related macular degeneration is an acquired degenerative disease that is responsible
for severe loss of vision in elderly people. There are two types: dry age-related macular …

Purpose Anti–vascular endothelial growth factor (VEGF) medications for intraocular use are
a major and increasing cost, and biosimilars may be a means of reducing the high cost of …

The ever-broadening scope of pharmaceuticals now available to treat previously untreatable
conditions, such as advanced metastatic cutaneous melanoma, have resulted in unintended …

Purpose A comparison of anti–vascular endothelial growth factor (anti-VEGF) medication
use across multiple countries. Clinical Relevance Anti-VEGF medication use is now …

Objectives To compare the efficacy and safety of conventional and navigated laser
photocoagulation as the primary treatment option for retinal arteriolar macroaneurysm …

Abstract Ziv‐aflibercept (Zaltrap®), a recombinant fusion protein that binds diffusible
vascular endothelial growth factor (VEGF), is approved for the treatment of metastatic …

This systematic review assessed the long-term outcomes for patients treated with intravitreal
antivascular endothelial growth factor or dexamethasone for macular oedema (MO) …

Purpose To compare the effectiveness of intravitreal ziv-aflibercept (IVZ) to intravitreal
bevacizumab (IVB) administered preoperatively to patients undergoing pars plana …